EUVIMEDEUVIMED entdecken
Open Access

Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy

Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Sotaro Goto, Yasuhiko Yamamura, Yusuke Masuda, Kumiko Fujita, Kento Ishimine, Yudai Hayashi, Mano Mino, An Ohigashi, Yuka Morita und 14 weitere

Journal of Clinical and Experimental Hematopathology · 2024

DOI: 10.3960/jslrt.24009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2024. Verfasst von Yu Yagi und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveLymphoma, Large B-Cell, DiffuseHumansMaleFemaleMiddle AgedAgedAdultRetrospective StudiesPrognosisHematopoietic Stem Cell TransplantationReceptors, Chimeric AntigenRecurrence

Stichwörter der Autor:innen

autologous stem cell transplantationchimeric antigen receptor T-cell therapyearly relapseprimary refractoryrelapsed or refractory diffuse large B-cell lymphoma

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Department of Pharmacy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Department of Radiation Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.

Zitieren

APA

Yagi, Y., Kanemasa, Y., Sasaki, Y., Goto, S., Yamamura, Y., Masuda, Y., Fujita, K., Ishimine, K., Hayashi, Y., Mino, M., Ohigashi, A., Morita, Y., Tamura, T., Nakamura, S., Okuya, T., Matsuda, S., Shimizuguchi, T., Shingai, N., Toya, T., …, & Shimoyama, T. (2024). Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.24009

Vancouver

Yagi Y, Kanemasa Y, Sasaki Y, Goto S, Yamamura Y, Masuda Y, et al. Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy. Journal of Clinical and Experimental Hematopathology. 2024. doi:10.3960/jslrt.24009

BibTeX
@article{Yagi2024,
  author = {Yagi, Yu and Kanemasa, Yusuke and Sasaki, Yuki and Goto, Sotaro and Yamamura, Yasuhiko and Masuda, Yusuke and Fujita, Kumiko and Ishimine, Kento and Hayashi, Yudai and Mino, Mano and Ohigashi, An and Morita, Yuka and Tamura, Taichi and Nakamura, Shohei and Okuya, Toshihiro and Matsuda, Shinichiro and Shimizuguchi, Takuya and Shingai, Naoki and Toya, Takashi and Shimizu, Hiroaki and Najima, Yuho and Kobayashi, Takeshi and Haraguchi, Kyoko and Doki, Noriko and Okuyama, Yoshiki and Shimoyama, Tatsu},
  title = {Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2024},
  doi = {10.3960/jslrt.24009}
}
Kostenlos starten →